InvestorsHub Logo

Omar8

12/30/21 6:29 AM

#14602 RE: exploremore #14600

Exploremore,



"BUT who cares, how many times does a patent have to prove itself worthless until it becomes worthless?"


Maybe they aren't completely worthless ? Perhaps in someone else's hands they could be something but these clowns don't know how to take it to next level ?


There could be other variables, maybe it's worth so much and someone else wants 5X what someone is asking ? Maybe someone thinks If patents in their name they have leverage and maybe someone is old and is stubborn and rather let the ship sink than in their eyes give it away at someone's else price ? Just my opinion, this captain thinks even if ship goes down he's not going down with it ?

Who knows ? But it's pretty clear these clowns even if something does have value haven't taken it anywhere for shareholders could be really proud of.






Here is something 5 years ago....

In response to queries coming to our office regarding our customization of the N-Assay for a multibillion medical technology company: we have sold 600+ of the N-Assay to them and will be supplying more in addition to further customization for other bacteria in 2017. As our arrangement with the client is CONFIDENTIAL, we will not be releasing their name.

Oct. 14, 2019

NanoLogix Provides Update on Development

NanoLogix is pleased to provide this brief update on the development on the N-Assay Bacteria Diagnostic Screening/Pretest. The development work in the UK by a company with Global operations began on October 1st and is in the first of four phases that will carry through to patient studies in Houston planned for 2020. This schedule will lead to marketing of both the N-Assay and its associated screening pretest for UTI (Urinary tract infections) projected for 2021.